Radiostereometric Analysis of Spine Arthrodesis
1 other identifier
observational
30
1 country
1
Brief Summary
The primary objective of this pilot study is to determine the precision of post-operative radiostereometric measurements for the assessment of lumbar spinal fusion. This study will also determine the potential for RSA as a more precise and accurate means for assessment of lumbar spinal fusion and diagnosis of pseudarthrosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedFirst Posted
Study publicly available on registry
November 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedJune 11, 2013
June 1, 2013
2.2 years
October 31, 2012
June 10, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Intervertebral motion post-op lumbar fusion
The purpose of this radiostereometric analysis (RSA) evaluation is to measure relative intervertebral motion in lumbar spinal fusions. Two RSA loading provocation protocols will be employed in this study; sitting and supine extension. Both loading protocols will be compard to a standard supine position which is used as an unloaded baseline protocol. Induced intervetebral motion sets will be calculated between the two loaded states, sitting and supine extension, and the unloaded state. The RSA micromotion results will be calculated and reported as translations and rotations about the three anatomic axes, maximum total point motion (MTPM) will be calculated as well.
2 years
Study Arms (3)
Radiostereometric analysis - Intact fusion
Clinically fused per classical radiographic assessment (≤ 2 degrees angular motion and evidence of bone bridging)
Radiostereometric analysis - Symptomatic pseudoarthrosis
Definitive clinical evidence of pseudarthrosis (not fused, ˃ 2 degrees angular motion or absence of bone bridge) and scheduled for surgical exploration
Radiostereometric analysis - Asymptomatic pseudoarthrosis
Definitive clinical evidence of pseudarthrosis without scheduled surgical exploration.
Interventions
The radiostereometric (RSA) patient exam (flexion and extension RSA images) presents additional radiation exposure to the patient above standard of care (additional radiographs). Assuming 120kV, using three protocols (two loaded and one unloaded) per RSA exam results in a typical effective dose of approximately 2.04mSv per exam(single lumbar spine RSA at 120kV yields 0.68mSv,). HBI recommends using 140kV for lumbar spine RSA and has conducted simulations to estimate the effective dose using higher kV settings. 140kV reduces the effective dose from 0.68mSv per spine RSA to 0.2mSV, resulting in a total effective dose per RSA exam of 0.6mSv. In comparison, the estimated effective dose for a single standard lumbar spine x-ray is 1.2mSv. This additional radiation exposure is considered to be minimal risk in consideration of the number of planar x-rays the patient will undergo as part of standard care, as well as average background radiation received by humans per year (3.1mSv).
Eligibility Criteria
Patients between the ages of 18 and 75 that are diagnosed with lumbar DDD (L1-L5, and also L5-S1) and scheduled for one or multi level spinal fusion surgery will be recruited for the study.
You may qualify if:
- Symptomatic degenerative disc disease of the lumbar spine indication surgical intervention
- Scheduled to undergo lumbar fusion surgery
- Patients between the ages of 18 and 75
- Ability to give informed consent
You may not qualify if:
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- OAD Orthopaedicslead
- Halifax Biomedical Inc.collaborator
- Central DuPage Hospitalcollaborator
Study Sites (1)
OAD Orthopaedics
Warrenville, Illinois, 60555, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Andreshak, MD
OAD Orthopaedics
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2012
First Posted
November 6, 2012
Study Start
November 1, 2012
Primary Completion
January 1, 2015
Study Completion
January 1, 2016
Last Updated
June 11, 2013
Record last verified: 2013-06